Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Health

Results: 265-276 of 8083

Business Wire logo

Compass Pathways Successfully Achieves Primary Endpoint in Second Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression

Business Wire logo

BeOne Medicines to Present at Upcoming Investor Conferences

PR Newswire associated0

Fresha Sets New Industry Standard: AI Agent Nova Now Resolves Over 80% of All Customer Support Tickets with a 4.6/5 Customer Satisfaction Rating

PR Newswire associated0

Lenire Shows Consistent Positive Results for U.S. Tinnitus Patients in 2nd Peer-Reviewed Real-World Study

Beactica and KU Leuven secure EUR 2.5 million from the European Innovation Council to advance orphan drug BEA-17 to clinical readiness

Specsavers Partners with Relationship Expert Paul Brunson to Reveal How Hearing Loss Affects Connection

UK hands over modernised rehabilitation wards to Ukraine Armed Forces

Parents urged to protect children through vaccination campaign

Business Wire logo

Compass Pathways to Announce New Clinical Data from Two Ongoing Phase 3 Trials

PR Newswire associated0

Zemcelpro® (dorocubicel) receives NUB Status 1 in Germany

British Sauna Society : New University of Greenwich research finds collective sauna rituals associated with a deep sense of belonging and greater physical and mental wellbeing

Business Wire logo

New ECCO data show subcutaneous (SC) infliximab (Remsima™ SC) effectively recaptures and maintains disease control after drug holiday

  • Prev Page
  • 1
  • 2
  • …
  • 22
  • 23
  • 24
  • …
  • 673
  • 674
  • Next Page

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2026

Terms of Use

Privacy Policy

Contact Us